Renal L-type and T-type voltage-gated calcium channels (Renal L/T-type VGCCs)

Renal L-type and T-type calcium channels are voltage-gated ion channels located within the renal vasculature and tubules that play a critical role in regulating kidney function and systemic blood pressure. L-type channels (primarily Cav1.2) are predominantly expressed in the afferent arterioles, where their activation leads to vasoconstriction and increased intraglomerular pressure (PubMed: 15596861). In contrast, T-type channels (primarily Cav3.2) are found in both afferent and efferent arterioles, as well as the podocytes and distal tubules (PubMed: 21178013). Dual inhibition of these channels is a significant therapeutic strategy because, unlike L-type selective blockers which may increase glomerular pressure, T-type blockade promotes efferent vasodilation, thereby reducing glomerular capillary pressure and providing superior renoprotection (StatPearls: NBK542176). These channels are key targets for calcium channel blockers (CCBs) like benidipine and cilnidipine, which are used to treat hypertension and slow the progression of chronic kidney disease and diabetic nephropathy (PubMed: 17633507).

Other names

Voltage-dependent calcium channelsCav1.2Cav3.2L-type calcium channelT-type calcium channelLow-voltage-activated calcium channelsHigh-voltage-activated calcium channels

Inhibition of L-type calcium channels primarily causes vasodilation of the afferent arterioles, while inhibition of T-type calcium channels causes vasodilation of both afferent and efferent arterioles, leading to reduced intraglomerular pressure.